Literature DB >> 22210088

Is there such a thing as a cancer treatment that isn't worth its cost?

Timothy Gilligan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22210088      PMCID： PMC3267819          DOI： 10.1634/theoncologist.2011-0302

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  8 in total

1.  The price tag on progress--chemotherapy for colorectal cancer.

Authors:  Deborah Schrag
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

2.  Illness and injury as contributors to bankruptcy.

Authors:  David U Himmelstein; Elizabeth Warren; Deborah Thorne; Steffie Woolhandler
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Jun       Impact factor: 6.301

3.  Who really pays for health care? The myth of "shared responsibility".

Authors:  Ezekiel J Emanuel; Victor R Fuchs
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

4.  Medical bankruptcy in the United States, 2007: results of a national study.

Authors:  David U Himmelstein; Deborah Thorne; Elizabeth Warren; Steffie Woolhandler
Journal:  Am J Med       Date:  2009-06-06       Impact factor: 4.965

5.  Bevacizumab in clinical practice: prescribing appropriateness relative to national indications and safety.

Authors:  Martina Bonifazi; Marta Rossi; Lorenzo Moja; Vincenzo Davide Scigliano; Matteo Franchi; Carlo La Vecchia; Carlo Zocchetti; Eva Negri
Journal:  Oncologist       Date:  2011-12-30

6.  Projections of the cost of cancer care in the United States: 2010-2020.

Authors:  Angela B Mariotto; K Robin Yabroff; Yongwu Shao; Eric J Feuer; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2011-01-12       Impact factor: 13.506

7.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer.

Authors:  Paul L Nguyen; Xiangmei Gu; Stuart R Lipsitz; Toni K Choueiri; Wesley W Choi; Yin Lei; Karen E Hoffman; Jim C Hu
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

8.  Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; Piotr Tomczak; M Dror Michaelson; Ronald M Bukowski; Stéphane Oudard; Sylvie Negrier; Cezary Szczylik; Roberto Pili; Georg A Bjarnason; Xavier Garcia-del-Muro; Jeffrey A Sosman; Ewa Solska; George Wilding; John A Thompson; Sindy T Kim; Isan Chen; Xin Huang; Robert A Figlin
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544
  8 in total
  1 in total

1.  Reply to: Gilligan T. Is there such a thing as cancer treatment that isn't worth its cost? The oncologist 2012;17:3-4.

Authors:  Donna Marie Graham; Seamus O'Reilly
Journal:  Oncologist       Date:  2013
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.